3 hasil
Menampilkan 1–3 · 0,18 detik · RSS
NEJM Evidence
Scopus
ISSN 2766-5526 · 3 artikel di indeks
-
Artikel Jurnal Teks lengkap
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
Background: Clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS) are defined by somatic mutations in genes associated with myeloid neoplasms (MN) at a variant allele fraction (VAF) ≥ 0.02, in the absence and presence of cytopenia…
-
Artikel Jurnal Teks lengkap
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
BACKGROUND: A single, high priming dose of tremelimumab (anti-cytotoxic T lymphocyte–associated antigen 4) plus durvalumab (anti–programmed cell death ligand-1), an infusion regimen termed STRIDE (Single Tremelimumab Regular Interval Durvalumab), showed encouraging clinical activity and safety in a…
-
Artikel Jurnal
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
BACKGROUND: Risk stratification and therapeutic decision-making for myelodysplastic syndromes (MDS) are based on the International Prognostic Scoring System–Revised (IPSS-R), which considers hematologic parameters and cytogenetic abnormalities. Somatic gene mutations are not yet used in the risk…